Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 4/20 | 0.44 |
| ▸ | EGFR | P00533 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.42 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.42 |
| ▸ | TDP2 | O95551 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26855338 | 0.88 | IDO1 (0.47) | KMT2AAPAF1IDO1MEN1TDO2 | |
| SCHEMBL26855331 | 0.87 | KMT2A (0.49) | KMT2AAPAF1IDO1EGFRMEN1 | |
| SCHEMBL26614209 | 0.86 | APAF1 (0.63) | KMT2AAPAF1IDO1EGFRMEN1 | |
| SCHEMBL26855335 | 0.80 | APAF1 (0.48) | KMT2AAPAF1IDO1EGFRMEN1 | |
| SCHEMBL26855341 | 0.75 | MEN1 (0.43) | KMT2AAPAF1IDO1EGFRMEN1 | |
| SCHEMBL26614193 | 0.73 | IDO1 (0.63) | KMT2AAPAF1IDO1MEN1TDO2 | |
| SCHEMBL31382838 | 0.73 | IDO1 (0.63) | KMT2AAPAF1IDO1MEN1TDO2 | |
| SCHEMBL20597470 | 0.72 | IDO1 (0.73) | APAF1IDO1 | |
| SCHEMBL19456418 | 0.72 | IDO1 (0.73) | APAF1IDO1 | |
| SCHEMBL31382877 | 0.71 | TDO2 (0.69) | KMT2AAPAF1IDO1MEN1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023211977-A1 | TRYPTANTHRIN DERIVATIVES AND USES THEREOF | VISCIENT BIO, INC. (US) | 2023-11-02 | — | — | WO | disclosed |